Company intelligence / Profile preview

BioBroker

Sydney, New South Wales, Australia

Ownership: Private
Development stage: Other

Overview

BioBroker is a specialized business development and licensing consultancy serving the global life sciences, biotechnology, and pharmaceutical industries. The company provides strategic advice and execution services for out-licensing, in-licensing, mergers and acquisitions, and strategic partnerships. With a focus on bridging the gap between research-driven organizations and commercial partners, BioBroker assists clients in valuing assets, identifying potential partners, and negotiating complex transactions. Their expertise spans various therapeutic areas and stages of development, from pre-clinical assets to marketed products.

Industry: Consulting

Beyond the preview

Go deeper on BioBroker.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioBroker.

Explore the full profile